Fingerprint
Dive into the research topics where Marianna Jasenecova is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial
Cope, A., Jasenecova, M., Carvalho Vasconcelos, J., Qureshi, S., van Schie, K. A., Filer, A., Raza, K., D'Agostino, M. A., McInnes, I. B., Siebert, S., Isaacs, J. D., Pratt, A. G., Fisher, B. A., D Buckley, C., Emery, P., Mankia, K., Ho, P., Buch, M., Ciurtin, C. & van Schaardenburg, D. & 6 others, , Mar 2026, In: The Lancet Rheumatology. 8, 3, p. e171-e180 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
Serum Proteomic Signatures of Rheumatoid Arthritis Risk and Response: Analysis of a Rheumatoid Arthritis Interception Trial
Jasenecova, M., Coyle, C., Mihalovits, A., Ryan, S., Pook, E., Perucha, E., Harker, G., Chin, M., Norton, S. & Cope, A., 9 Feb 2026, (E-pub ahead of print) In: Arthritis and Rheumatology. p. 1-11Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY
Cope, A., Jasenecova, M., Carvalho Vasconcelos, J., Filer, A., Raza, K., Qureshi, S., D'Agostino, M. A., McInnes, I. B., Siebert, S., Isaacs, J., Pratt, A. G., Fisher, B. A., Buckley, C. D., Emery, P., Mankia, K., Ho, P., Buch, M., Ciurtin, C., van Schaardenburg, D. & Huizinga, T. & 3 others, , 2025, In: Annals of the Rheumatic Diseases. 84, Supplement 1, p. 4-5Research output: Contribution to journal › Meeting Abstract
Open Access -
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial
Cope, A., Jasenecova, M., Vasconcelos, J., Filer, A., Raza, K., Qureshi, S., D'Agostino, M. A., McInnes, I., Isaacs, J., Pratt, A. G., Fisher, B. A., Buckley, C. D., Emery, P., Ho, P., Buch, M. H., Ciurtin, C., van Schaardenburg, D., Huizinga, T. W. J., Toes, R. & Georgiou, E. & 4 others, , 2 Mar 2024, In: The Lancet. 403, 10429, p. 838-849 12 p.Research output: Contribution to journal › Article › peer-review
Open Access140 Citations (Scopus) -
OP0130 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL
Cope, A., Jasenecova, M., Carvalho Vasconcelos, J., Filer, A., Raza, K., Qureshi, S., D’Agostino, M. A., McInnes, I., Isaacs, J., Pratt, A., Fisher, B., Buckley, C. D., Emery, P., Ho, P., Buch, M. H., Ciurtin, C., Huizinga, T., van Schaardenburg, D., Murphy, C. & Prevost, T., 30 May 2023, In: Annals of the Rheumatic Diseases. 82, Issue Suppl 1, p. 86 1 p.Research output: Contribution to journal › Meeting Abstract
Open Access